C. Schultz

发表

Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

J. Jacobs, T. Pajak, J. Cooper, 2004, The New England journal of medicine.

Planning quality and delivery efficiency of sMLC delivered IMRT treatment of oropharyngeal cancers evaluated by RTOG H‐0022 dosimetric criteria

Christopher J. Schultz, Michael T. Gillin, X. Zhu, 2004, Journal of applied clinical medical physics.

Interfractional variations in patient setup and anatomic change assessed by daily computed tomography.

X Sharon Qi, Christopher J Schultz, X Allen Li, 2007, International journal of radiation oncology, biology, physics.

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Walter J. Curran, Mark R. Gilbert, Jean-Paul Bahary, 2016, The New England journal of medicine.

Stage I and II Hodgkin's disease in the pediatric population. Long-term follow-up of patients staged predominantly clinically.

C. Schultz, J. Wilson, K. Murray, 1996, American journal of clinical oncology.

Carcinoma of the larynx in patients with gastroesophageal reflux.

B. Woodson, B. Campbell, C. Schultz, 1996, American journal of otolaryngology.

Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.

B. Campbell, C. Schultz, Dian Wang, 2008, International journal of radiation oncology, biology, physics.

Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation.

C. Geard, C. Schultz, Charles R. Geard, 1990, International journal of radiation oncology, biology, physics.

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.

W. Curran, M. Mehta, R. Timmerman, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An on-line replanning method for head and neck adaptive radiotherapy.

Ergun E Ahunbay, X Allen Li, Christopher Schultz, 2009, Medical physics.

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.

Maria Werner-Wasik, Lucia Zamorano, Walter J Curran, 2004, International journal of radiation oncology, biology, physics.

GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas: A Retrospective Multi-institutional Analysis

S. Green, S. Tatter, K. Bastin, 2006, Neurosurgery.

In reply to Dr. Kondziolka et al

P. Okunieff, W. Curran, D. Brachman, 2005 .

In response to Drs. Vordermark and Kölbl

P. Okunieff, W. Curran, D. Brachman, 2005 .

RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM).

K. Aldape, W. Curran, Meihua Wang, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.

X Allen Li, Scott D Rand, Christopher J Schultz, 2006, International journal of radiation oncology, biology, physics.

Radiotherapy: Is Conventional Dose Fractionation Necessary?

V. Semenenko, R. Byhardt, C. Schultz, 2012 .

Dynamic MRI analysis of tumor and organ motion during rest and deglutition and margin assessment for radiotherapy of head-and-neck cancer.

Eric S. Paulson, Ergun Ahunbay, X. Allen Li, 2011, International journal of radiation oncology, biology, physics.

Technical Note: Dose effects of 1.5 T transverse magnetic field on tissue interfaces in MRI-guided radiotherapy.

X. Li, Guang-Pei Chen, P. Prior, 2016, Medical physics.

Precision Oncology and Genomically Guided Radiation Therapy, A Report From the ASTRO/AAPM/NCI Precision Medicine Conference

C. N. Coleman, Reid F Thompson, C. Coleman, 2017 .

The role of pre-treatment white matter abnormalities in developing white matter changes following whole brain radiation: a volumetric study

P. LaViolette, W. Mueller, D. Sabsevitz, 2013, Journal of Neuro-Oncology.

Planned postradiotherapy neck dissection in patients with advanced head and neck cancer

P. Harari, C. Schultz, R. Foote, 1998, Head & neck.

The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.

Christopher U. Jones, A. Garden, R. Weber, 2021, Journal of geriatric oncology.

Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation.

M. Stadler, M. Awan, B. Campbell, 2019, American journal of otolaryngology.

Demonstration of a brachytherapy boost dose-response relationship in glioblastoma multiforme: headed in the right direction.

C. Schultz, 1996, International journal of radiation oncology, biology, physics.

Central lymphatic irradiation for stage III nodular malignant lymphoma: long-term results.

J. Cox, M. Goswitz, C. Schultz, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.

D. Brat, M. Mehta, B. Fisher, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck.

C. Schultz, N. Choong, Dian Wang, 2012, International journal of radiation oncology, biology, physics.

Risk factors which predict persistent cancer in the abnormal larynx following definitive irradiation.

B. Campbell, C. Schultz, J. Freije, 1995, European journal of cancer. Part B, Oral oncology.

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy

B. Erickson, C. Fuller, R. Huddart, 2020, Frontiers in Oncology.

Survival a nd N eurologic O utcomes i n a R andomized T rial o f Motexafin G adolinium a nd W hole-Brain R adiation T herapy i n Brain M etastases

W. Curran, M. Mehta, R. Timmerman, 2003 .

Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting

J. Bovi, C. Schultz, A. Elson, 2015, Front. Oncol..

Using rCBV to Distinguish Radiation Necrosis from Tumor Recurrence in Malignant Gliomas

K. Schmainda, H. Krouwer, S. Rand, 2005 .

Lymphoepithelioma of the larynx.

R. Komorowski, B. Campbell, C. Schultz, 1996, American journal of otolaryngology.

Imaging of osteoid osteoma with dynamic gadolinium-enhanced MR imaging.

Patrick T. Liu, C. Roberts, C. Beauchamp, 2003, Radiology.

Patterns of failure for resected advanced head & neck cancer treated by concurrent chemotherapy and radiation therapy: an analysis of RTOG 9501/intergroup phase III trial

J. Jacobs, T. Pajak, J. Cooper, 2002 .

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.

D. Nelson, W. Curran, M. Mehta, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order.

M. Mehta, B. Corn, J. Bovi, 2018, International journal of radiation oncology, biology, physics.

Gliasite radiotherapy system for treatment of recurrent malignant glioma: A multi-institutional analysis

S. Green, K. Bastin, B. Stea, 2004 .

Primary central nervous system histiocytic sarcoma with relapse to mediastinum: a case report and review of the literature.

C. Chang, Y. Zu, C. Schultz, 2007, Archives of pathology & laboratory medicine.

ATCT-09IDH1 R132H MUTATIONS IN NRG ONCOLOGY/RTOG 9802: PHASE III STUDY OF RADIATION THERAPY (RT) ALONE VS RT PLUS PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN PATIENTS WITH LOW GRADE GLIOMA (LGG).

E. Shaw, W. Curran, S. Coons, 2015 .

AT-13R9802: PHASE III STUDY OF RADIATION THERAPY (RT) WITH OR WITHOUT PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN LOW-GRADE QLIOMA: RESULTS BY HISTOLOGIC TYPE

E. Shaw, W. Curran, S. Coons, 2014 .

Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG.

E. Shaw, W. Curran, S. Coons, 2014 .

4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience

B. Erickson, X. Li, E. Ahunbay, 2020, Clinical and translational radiation oncology.

2739 : Inter-Fractional Variations in Patient Setup and Anatomic Change Assessed by Daily CT From Helical Tomotherapy

B. Erickson, X. Li, P. Jursinic, 2006 .

Motexafin gadolinium prolongs time to neurologic progression in lung cancer patients with brain metastases: results of a randomized phase III trial

W. Curran, M. Mehta, Jennifer A. Smith, 2002 .

Safety and feasibility of motexafin gadolinium administration with whole brain radiation therapy and stereotactic radiosurgery boost in the treatment of ≤6 brain metastases: a multi-institutional phase II trial

D. Brachman, M. Mehta, R. Timmerman, 2011, Journal of Neuro-Oncology.

Giant cell Carcinoma of the Parotid Gland

C. Schultz, L. Clowry, J. Freije, 1996, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Continuous split course irradiation for stage I and II Hodgkin's disease: 20 year experience at the Medical College of Wisconsin.

J. Cox, C. Schultz, J. Wilson, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

K. Ang, J. Jacobs, T. Pajak, 2012, International journal of radiation oncology, biology, physics.

The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525.

J. Herman, M. Gilbert, M. Mehta, 2019, Neuro-oncology practice.

American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Stereotactic Radiosurgery (SRS)

Louis Potters, Christopher J Schultz, James M Galvin, 2013, American journal of clinical oncology.

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

Walter J Curran, Deborah T Blumenthal, Mark R Gilbert, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patterns of care, tolerability and safety of the first cohort of patients treated on a novel high-field MR-Linac within the MOMENTUM Study: Initial results from a prospective Multi-Institutional Registry.

B. Erickson, C. Fuller, R. Huddart, 2021, International journal of radiation oncology, biology, physics.

In Reply to Peñagarícano.

J. Bovi, C. Schultz, 2021, International journal of radiation oncology, biology, physics.

2800 : Ranking Complex IMRT Plans Using an EUD-Based Figure-of-Merit Index

K. Ruchala, G. Olivera, K. Kainz, 2006 .

Case report: Fractional brain tumor burden magnetic resonance mapping to assess response to pulsed low-dose-rate radiotherapy in newly-diagnosed glioblastoma

W. Mueller, E. Cochran, K. Schmainda, 2022, Frontiers in Oncology.

A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis.

M. Mehta, J. Buatti, E. Alexander, 1996, International journal of radiation oncology, biology, physics.

Secondary Analysis of Radiation Therapy Oncology Group study (RTOG) 9310: An Intergroup Phase II Combined Modality Treatment of Primary Central Nervous System Lymphoma

D. Nelson, W. Curran, M. Mehta, 2005, Journal of Neuro-Oncology.

Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

L. Deangelis, B. Fisher, S. Schold, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late-Onset Chemosis in Patients with Head or Neck Tumors

C. Schultz, K. Woo, G. Harris, 2004, Ophthalmic plastic and reconstructive surgery.

Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.

M. Prados, T. Cascino, W. Curran, 2004, International journal of radiation oncology, biology, physics.

Iododeoxyuridine radiosensitization of human glioblastoma cells exposed to acute and chronic gamma irradiation: mechanistic implications and clinical relevance.

M. Lindstrom, D. Gaffney, T. Kinsella, 1995, The cancer journal from Scientific American.

Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)

M. Mehta, K. Camphausen, B. Corn, 2013, Biomarker Research.

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.

W. Curran, Meihua Wang, D. Brachman, 2013, International journal of radiation oncology, biology, physics.

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial

K. Aldape, M. Mehta, B. Fisher, 2018, JAMA oncology.

Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813

Susan M. Chang, K. Aldape, D. Brachman, 2016, Neuro-oncology.

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.

K. Aldape, E. Shaw, D. Brachman, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)

M. Suntharalingam, J. Cooper, E. Sturgis, 2016, Cancer.

BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort

M. Prados, W. Curran, J. Knisely, 2021, Oncology.

Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.

C. N. Coleman, Reid F Thompson, J. Weidhaas, 2017, International journal of radiation oncology, biology, physics.

Expression of p53, c-Myc, or Bcl-6 suggests a poor prognosis in primary central nervous system diffuse large B-cell lymphoma among immunocompetent individuals.

Chung-Che Chang, Brent Logan, Christopher Schultz, 2003, Archives of pathology & laboratory medicine.

Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer.

R. Jackson, M. Stadler, M. Awan, 2019, Oral oncology.

Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131.

J. Herman, P. Brown, M. Mehta, 2009, Neuro-oncology.

Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710.

D. Nelson, M. Mehta, W. Yung, 2006, International journal of radiation oncology, biology, physics.

A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023

M. Mehta, A. Chakravarti, M. Gillin, 2006 .

Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021.

Christopher J Schultz, D. Brachman, M. Mehta, 2006, Neuro-oncology.

Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme : RTOG protocol BR-00211

D. Brachman, M. Mehta, H. Robins, 2005 .

Combination C hemotherapy a nd R adiotherapy f or P rimary Central N ervous S ystem L ymphoma: R adiation T herapy Oncology G roup S tudy 9 3-10

L. Deangelis, B. Fisher, S. Schold, 2002 .

RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck.

S. Spencer, W. Spanos, R. Meredith, 2001, International journal of radiation oncology, biology, physics.

Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06.

D. Nelson, B. Fisher, B. Corn, 2000, International journal of radiation oncology, biology, physics.

Characterization of Underrepresented Populations in Modern Era Clinical Trials Involving Radiation Therapy.

B. Erickson, A. Banerjee, M. Siker, 2021, Practical radiation oncology.

Semicontinuous low-dose-rate teletherapy for the treatment of recurrent glial brain tumors: final report of a phase I/II study.

M. Siker, H. Krouwer, C. Schultz, 2008, International journal of radiation oncology, biology, physics.

Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians

A. Kishan, B. Erickson, X. Li, 2021, CA: a cancer journal for clinicians.

Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer.

J. Blumin, B. Campbell, C. Schultz, 2011, International journal of radiation oncology, biology, physics.

Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05).

E. Shaw, R. Dinapoli, B. Fisher, 1996, International journal of radiation oncology, biology, physics.

The transformation of radiation oncology using real-time magnetic resonance guidance: A review.

David A Jaffray, X Allen Li, Clifton D Fuller, 2019, European journal of cancer.

Current radiosurgery practice: results of an astro survey

E. Shaw, M. Mehta, J. Palta, 1994 .

Role of radiation therapy in cutaneous melanoma.

M. Siker, M. Daly, C. Schultz, 2010, Clinics in plastic surgery.

Effect of image uncertainty on the dosimetry of trigeminal neuralgia irradiation.

P. Jursinic, T. Gennarelli, C. Schultz, 2005, International journal of radiation oncology, biology, physics.

79 : Phase II Multi-institutional Study of IMRT for Oropharyngeal Cancer (RTOG 00-22): Early Results

A. Garden, K. Ang, G. Sanguineti, 2006 .

Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes

W. Mueller, K. Schmainda, M. Siker, 2020, International journal of radiation oncology, biology, physics.

Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck

S. Spencer, K. Ang, W. Spanos, 2008, Head & neck.

Possible fractionated regimens for image-guided intensity-modulated radiation therapy of large arteriovenous malformations

X. Li, C. Schultz, X. Qi, 2007, Physics in medicine and biology.

Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points.

W. Curran, M. Mehta, Jennifer A. Smith, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review

M. Siker, E. Gore, J. Bovi, 2018, Neurosurgery.

Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma

P. LaViolette, W. Mueller, E. Cochran, 2016, American Journal of Neuroradiology.

Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.

W. Curran, Meihua Wang, M. Mehta, 2019, International journal of radiation oncology, biology, physics.

An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor.

X. Li, C. Schultz, X. Qi, 2006, International journal of radiation oncology, biology, physics.

Current management of primary central nervous system lymphoma.

J. Bovi, C. Schultz, 2010, International journal of radiation oncology, biology, physics.

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients

Christopher U. Jones, A. Markoe, W. Yung, 2018, Journal of Neuro-Oncology.

Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522.

M. Suntharalingam, Q. Zhang, J. Barnholtz-Sloan, 2021, Oral oncology.

Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary?

V. Semenenko, R. Byhardt, C. Schultz, 2012, International journal of radiation oncology, biology, physics.

The role of dental prostheses in alveolar ridge squamous carcinomas.

D. Mark, B. Campbell, C. Schultz, 1997, Archives of otolaryngology--head & neck surgery.

ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS

K. Aldape, E. Shaw, S. Coons, 2017 .

Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer.

X. Li, Shouping Xu, Cungen Yang, 2015, International journal of radiation oncology, biology, physics.

Serial T2-Weighted Magnetic Resonance Images Acquired on a 1.5 Tesla Magnetic Resonance Linear Accelerator Reveal Radiomic Feature Variation in Organs at Risk: An Exploratory Analysis of Novel Metrics of Tissue Response in Prostate Cancer

X. Li, E. Paulson, C. Schultz, 2019, Cureus.

Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024.

A. Garden, K. Ang, R. Weber, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined online and offline adaptive radiation therapy: a dosimetric feasibility study.

Chengliang Yang, X Allen Li, Ergun Ahunbay, 2014, Practical radiation oncology.

Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study

T. Padhya, R. Jackson, M. Stadler, 2019, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.

M. Mehta, A. Chakravarti, M. Gillin, 2005, International journal of radiation oncology, biology, physics.

GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas: A Retrospective Multi-institutional Analysis

S. Green, S. Tatter, K. Bastin, 2006, Neurosurgery.

RTOG 0525: Molecular correlates from a randomized phase III trial of newly diagnosed glioblastoma.

K. Aldape, M. Gilbert, M. Mehta, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Secondary analysis of RTOG 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma with chemotherapy and hyperfractionated radiotherapy

D. Nelson, W. Curran, L. Deangelis, 2001 .

Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT.

X Allen Li, Xiaowu Deng, Christopher Schultz, 2018, International journal of radiation oncology, biology, physics.

Improving Structure Delineation for Radiation Therapy Planning Using Dual-Energy CT

X. Li, A. Tai, N. Mistry, 2020, Frontiers in Oncology.

American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT)

Geoffrey S Ibbott, Brian Kavanagh, Christopher J Schultz, 2012, American journal of clinical oncology.

Acinic Cell Carcinoma of the Major Salivary Glands: Analysis of Prognostic Factors in 2,950 patients

M. Stadler, B. Campbell, C. Schultz, 2018 .

Comparing the quality of passively-scattered proton and photon tomotherapy plans for brain and head and neck disease sites

M. Siker, K. Kainz, C. Schultz, 2015, Physics in medicine and biology.

Lymph node yield from neck dissection in HPV‐associated oropharyngeal cancer

R. Jackson, M. Stadler, M. Awan, 2020, The Laryngoscope.

American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT).

Geoffrey S Ibbott, Brian Kavanagh, Prabhakar Tripuraneni, 2009, International journal of radiation oncology, biology, physics.

Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology.

B. Erickson, M. Siker, C. Schultz, 2021, International Journal of Radiation Oncology, Biology, Physics.

ATCT-12RESULTS OF NRG ONCOLOGY/RTOG 9813- A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) THERAPY FOR ANAPLASTIC ASTROCYTOMA (AA)

Susan M. Chang, K. Aldape, D. Brachman, 2015 .

Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA).

Susan M. Chang, K. Aldape, D. Brachman, 2015 .

Pulsed reduced dose rate radiotherapy in conjunction with bevacizumab significantly extends survival over bevacizumab alone in recurrent high-grade glioma.

W. Mueller, K. Schmainda, M. Siker, 2020, International journal of radiation oncology, biology, physics.

Consensus statement on stereotactic radiosurgery: quality improvement.

L. Lunsford, E. Shaw, M. Mehta, 1994, Neurosurgery.

An on-line replanning method for head and neck adaptive radiotherapya).

Ergun E Ahunbay, X Allen Li, Christopher Schultz, 2009, Medical physics.

Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06.

R. Abrams, B. Fisher, C. Scott, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A closer look at 30 day hospital readmissions after head and neck cancer surgery.

R. Puccia, M. Stadler, M. Awan, 2021, American journal of otolaryngology.

Development of an inverse optimization package to plan nonuniform dose distributions based on spatially inhomogeneous radiosensitivity extracted from biological images.

X Allen Li, Ergun Ahunbay, Guang-Pei Chen, 2007, Medical physics.

Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United States

Fei Liu, R. Jagsi, L. Potters, 2023, Advances in radiation oncology.

Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy

P. Vantuinen, K. Christians, C. Schultz, 2009, International journal of hematology.

Randomized prospective comparison of stereotactic radiosurgery (SRS) followed by conventional radiotherapy (RT) with BCNU to RT with BCNU alone for selected patients with supratentorial glioblastoma multiforme (GBM): report of RTOG 93-05 protocol

P. Okunieff, W. Curran, D. Brachman, 2002 .

Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma.

B. Campbell, C. Schultz, Dian Wang, 2008, International journal of radiation oncology, biology, physics.

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes, NRG Oncology/RTOG 9501-0234.

M. Suntharalingam, J. Cooper, G. Laramore, 2015 .

The effect of age on outcome in prospective, phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- chemotherapy in locally advanced (LA) head and neck cancer (HNC).

Christopher U. Jones, A. Garden, R. Weber, 2015 .